• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气候变化是否应对严重口服皮质类固醇依赖型哮喘负责?病例报告。

Climate Change to Blame in Severe Oral Corticosteroid-Dependent Asthma? A Case Report.

机构信息

Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (mainland).

Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China (mainland).

出版信息

Am J Case Rep. 2020 Apr 18;21:e921120. doi: 10.12659/AJCR.921120.

DOI:10.12659/AJCR.921120
PMID:32303671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7193221/
Abstract

BACKGROUND Despite the availability of inhaled corticosteroid and the development of various biological treatment agents, severe asthma patients are still at high risk of recurrent and life-threatening exacerbations, which results in morbidity and mortality. In addition to treatment response variability, incorrect inhaler technique, poor adherence, and major psychological problems, environmental factors such as climate change also are contributory factors for worsen symptoms of asthma and acute exacerbation. We present here, a case of a 63-year-old female patient who had oral corticosteroid-dependent severe asthma and recurrent attacks in spring and autumn. CASE REPORT A 63-year-old Chinese female was diagnosed with asthma when she was 3 years old. During 2007-2011, she was admitted to the hospital once a year because of asthma exacerbation; she was on a regular treatment regimen of inhaled corticosteroids (ICS) plus long-acting beta-agonist (LABA). In October 2018, she was admitted to our Department for aggravating symptoms due to "sudden climate change". She was discharged on tapering doses of oral methylprednisolone from 32 mg once daily, but the reduced methylprednisolone resulted in aggravation of wheezing. However, when the weather warmed up, her symptoms were relieved, and she stopped taking methylprednisolone (after the tapering). CONCLUSIONS This study suggests an association between the common causes of weather changes and acute severe asthma exacerbation. Patients and clinicians should be aware that keeping warm and avoiding exposure to cold air and airborne allergens might reduce the frequency of asthma exacerbations.

摘要

背景 尽管有吸入性皮质类固醇和各种生物治疗药物的发展,严重哮喘患者仍有反复发作和危及生命的加重的高风险,这导致发病率和死亡率增加。除了治疗反应的可变性、不正确的吸入器技术、较差的依从性和主要的心理问题外,气候变化等环境因素也是哮喘症状恶化和急性加重的促成因素。我们在此介绍一例 63 岁女性患者,她患有口服皮质类固醇依赖的严重哮喘,春秋两季反复发作。

病例报告 一位 63 岁的中国女性,3 岁时被诊断为哮喘。2007 年至 2011 年期间,她每年因哮喘加重而住院一次;她接受了吸入皮质类固醇(ICS)加长效β激动剂(LABA)的常规治疗方案。2018 年 10 月,她因“突然气候变化”导致症状加重而入住我科。她接受了每日 32 毫克口服甲泼尼龙的逐渐减量治疗,但甲泼尼龙的减少导致喘息加重。然而,当天气变暖时,她的症状得到缓解,她停止服用甲泼尼龙(逐渐减量后)。

结论 本研究提示气候变化的常见原因与急性严重哮喘加重之间存在关联。患者和临床医生应意识到保持温暖和避免接触冷空气和空气传播过敏原可能会减少哮喘加重的频率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/991e17a471a4/amjcaserep-21-e921120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/77ac45889aa3/amjcaserep-21-e921120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/f002d8099c6e/amjcaserep-21-e921120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/719cd363266b/amjcaserep-21-e921120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/991e17a471a4/amjcaserep-21-e921120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/77ac45889aa3/amjcaserep-21-e921120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/f002d8099c6e/amjcaserep-21-e921120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/719cd363266b/amjcaserep-21-e921120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d501/7193221/991e17a471a4/amjcaserep-21-e921120-g004.jpg

相似文献

1
Climate Change to Blame in Severe Oral Corticosteroid-Dependent Asthma? A Case Report.气候变化是否应对严重口服皮质类固醇依赖型哮喘负责?病例报告。
Am J Case Rep. 2020 Apr 18;21:e921120. doi: 10.12659/AJCR.921120.
2
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.长效β2受体激动剂与抗白三烯药物联合吸入糖皮质激素治疗慢性哮喘的比较
Cochrane Database Syst Rev. 2011 May 11(5):CD003137. doi: 10.1002/14651858.CD003137.pub4.
3
Corticosteroid plus β-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.单吸入器中皮质类固醇加 β-激动剂作为间歇性和轻度哮喘缓解治疗的概念验证系统评价和荟萃分析。
Respir Res. 2017 Dec 6;18(1):203. doi: 10.1186/s12931-017-0687-6.
4
Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.不同吸入性糖皮质激素及其与长效β2受体激动剂联合使用治疗12岁及以上成人和儿童慢性哮喘比较效果的系统评价与经济学分析
Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. doi: 10.3310/hta12190.
5
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.吸入长效β2受体激动剂与吸入性糖皮质激素联合使用与高剂量吸入性糖皮质激素治疗儿童和成人持续性哮喘的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005533. doi: 10.1002/14651858.CD005533.
6
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.长效β2受体激动剂与抗白三烯药物作为吸入性糖皮质激素治疗慢性哮喘的附加疗法比较
Cochrane Database Syst Rev. 2006 Oct 18(4):CD003137. doi: 10.1002/14651858.CD003137.pub3.
7
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.长效β受体激动剂联合或单独使用吸入器作为接受吸入性糖皮质激素治疗但哮喘控制不佳儿童的升级治疗方案
J Allergy Clin Immunol Pract. 2017 Jan-Feb;5(1):99-106.e3. doi: 10.1016/j.jaip.2016.06.009. Epub 2016 Jul 13.
8
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.长效β2受体激动剂与抗白三烯药物作为吸入性糖皮质激素治疗慢性哮喘的附加疗法比较
Cochrane Database Syst Rev. 2005 Jan 25(1):CD003137. doi: 10.1002/14651858.CD003137.pub2.
9
Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.哮喘孕妇使用长效β₂-激动剂和吸入皮质类固醇联合治疗与高剂量吸入皮质类固醇单一疗法相比的先天畸形风险。
J Allergy Clin Immunol. 2015 Jan;135(1):123-30. doi: 10.1016/j.jaci.2014.07.051. Epub 2014 Sep 13.
10
Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.长效β2受体激动剂与安慰剂用于慢性哮喘儿童和成人并联合吸入性糖皮质激素的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005535. doi: 10.1002/14651858.CD005535.

本文引用的文献

1
Assessing effects of personal behaviors and environmental exposure on asthma episodes: a diary-based approach.评估个人行为和环境暴露对哮喘发作的影响:基于日记的方法。
BMC Pulm Med. 2019 Dec 2;19(1):231. doi: 10.1186/s12890-019-0998-0.
2
Chemistry-triggered events of PM explosive growth during late autumn and winter in Shanghai, China.中国上海深秋至冬季期间 PM 剧烈增长的化学触发事件。
Environ Pollut. 2019 Nov;254(Pt A):112864. doi: 10.1016/j.envpol.2019.07.032. Epub 2019 Jul 18.
3
Different endotypes and phenotypes drive the heterogeneity in severe asthma.
不同的表型和表型驱动严重哮喘的异质性。
Allergy. 2020 Feb;75(2):302-310. doi: 10.1111/all.13966. Epub 2019 Aug 4.
4
Association of molds and metrological parameters to frequency of severe asthma exacerbation.霉菌与计量参数和严重哮喘加重频率的关联
Allergy Asthma Clin Immunol. 2019 Apr 29;15:29. doi: 10.1186/s13223-019-0323-8. eCollection 2019.
5
Prevalence and risk factors of asthma in mainland China: The CARE study.中国大陆地区哮喘的患病率及危险因素: CARE 研究。
Respir Med. 2018 Apr;137:48-54. doi: 10.1016/j.rmed.2018.02.010. Epub 2018 Feb 16.
6
A summary of the new GINA strategy: a roadmap to asthma control.新全球哮喘防治创议(GINA)策略总结:哮喘控制路线图
Eur Respir J. 2015 Sep;46(3):622-39. doi: 10.1183/13993003.00853-2015. Epub 2015 Jul 23.
7
The prevalence of severe refractory asthma.严重难治性哮喘的患病率。
J Allergy Clin Immunol. 2015 Apr;135(4):896-902. doi: 10.1016/j.jaci.2014.08.042. Epub 2014 Oct 16.
8
The changing epidemiology of asthma in Shanghai, China.中国上海哮喘流行病学的变化
J Asthma. 2015 Jun;52(5):465-70. doi: 10.3109/02770903.2014.982762. Epub 2014 Nov 18.
9
The association between cold spells and pediatric outpatient visits for asthma in Shanghai, China.中国上海寒冷天气与儿科哮喘门诊就诊的相关性研究。
PLoS One. 2012;7(7):e42232. doi: 10.1371/journal.pone.0042232. Epub 2012 Jul 25.
10
Immune responses to exercising in a cold environment.对在寒冷环境中运动的免疫反应。
Wilderness Environ Med. 2011 Dec;22(4):343-51. doi: 10.1016/j.wem.2011.08.005. Epub 2011 Oct 7.